Iveta K.
- Country
- Latvia
- Department
- Private practice
Research Overview
- A 52-week, randomised, double blind, multicentre, 2-arm parallel group trial assessing the efficacy and safety of CHF6001 (total daily dose 3200 μg) Dry Powder Inhaler (DPI) add-on to maintenance medium or high dose inhaled corticosteroid in combination with long-acting ß2-agonists in subjects with uncontrolled asthma
- Efficacy and Safety of Tanimilast DPI as Add-On to Triple Therapy in Chronic Obstructive Pulmonary Disease with Chronic Bronchitis
- Evaluation of Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis: A Randomized, Double-Blind, Parallel Group, Roll-Over Study
Data & Insights
Has run more than one trial at 122 of 434 partner sites.
Specializations
Respiratory Disease Management
This investigator specializes in treating complex respiratory conditions, with particular expertise in bronchiectasis and its long-term therapeutic management. Their research encompasses innovative treatment approaches for chronic respiratory conditions.
- Bronchiectasis therapy evaluation
- Long-term respiratory treatment assessment
- Safety monitoring protocols
Their work focuses on evaluating novel therapeutic agents for managing bronchiectasis symptoms and improving patient outcomes.
Asthma Treatment Innovation
The investigator's work centers on developing enhanced treatments for uncontrolled asthma, particularly focusing on patients who require additional therapy beyond standard maintenance treatments.
- Advanced asthma therapeutics
- Combination therapy assessment
- Exacerbation reduction strategies
Their research explores new therapeutic options for patients with inadequate response to conventional inhaled corticosteroid treatments.
COPD Therapeutic Advancement
The investigator specializes in developing treatment strategies for Chronic Obstructive Pulmonary Disease, with particular focus on triple therapy applications and exacerbation management.
- Triple therapy optimization
- Advanced COPD management
- Exacerbation prevention protocols
Their expertise extends to evaluating enhanced therapeutic combinations for improving outcomes in COPD patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.